Article
Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer
Drug Design, Development and Therapy · 2016 · Chen S, Sun KX, Feng MX, Sang XB, Liu BL, Zhao Y
Key facts
| Title | Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer |
|---|---|
| First author | Chen S, Sun KX, Feng MX, Sang XB, Liu BL, Zhao Y |
| Journal | Drug Design, Development and Therapy |
| Published | Mar 18, 2016 |
| DOI | 10.2147/DDDT.S102506 |
| Devices mentioned | K810863 |
| Product codes mentioned | DBM |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1